Download Files:
SCO-267
SKU
HY-132265-1 mg
Category Reference compound
Tags Free Fatty Acid Receptor, GPCR/G Protein, Metabolic Disease
$170 – $3,650
Products Details
Product Description
– SCO-267 is an allosteric GPR40 full agonist. SCO-267 can be used for the research of chronic diseases including diabetes[1].
Web ID
– HY-132265
Storage Temperature
– -20°C, 3 years; 4°C, 2 years (Powder)
Shipping
– Room Temperature
Applications
– Metabolism-sugar/lipid metabolism
Molecular Formula
– C36H46N4O5
References
– [1]Koyama R, et al. Chronic Exposure to SCO-267, an Allosteric GPR40 Full Agonist, Is Effective in Improving Glycemic Control in Rats. Mol Pharmacol. 2021 Apr;99(4):286-293.
CAS Number
– 1656261-09-4
Molecular Weight
– 614.77
Compound Purity
– 99.31
SMILES
– CC(C)(C)CN(C1=CC=CC(C)=N1)C(C2=C(N3CCC(CC3)COC4=CC([C@H](C5CC5)CC(O)=O)=CC=N4)C=C(C=C2)OC)=O
Clinical Information
– No Development Reported
Research Area
– Metabolic Disease
Solubility
– DMSO : 100 mg/mL (ultrasonic)
Target
– Free Fatty Acid Receptor
Pathway
– GPCR/G Protein
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.